NCT01783587 2025-05-01
Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
Dana-Farber Cancer Institute
West China Hospital
Groupe Oncologie Radiotherapie Tete et Cou